Slow release carbamazepine in treatment of poorly controlled seizures
- PMID: 2221963
- PMCID: PMC1792095
- DOI: 10.1136/adc.65.9.930
Slow release carbamazepine in treatment of poorly controlled seizures
Abstract
Thirty three children with poorly controlled epilepsy, and six new patients, were treated with slow release carbamazepine. Twelve of the former had a reduction in the number of seizures of more than half, and 10 had fewer side effects. Three of the new patients stopped having seizures. Variations in plasma concentrations between doses was significantly less when patients took the slow release preparation (22%) compared with the standard preparation (41%). Slow release carbamazepine may improve the conditions of children whose seizures are poorly controlled.
Similar articles
-
Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.J Child Neurol. 1995 Mar;10(2):114-7. doi: 10.1177/088307389501000209. J Child Neurol. 1995. PMID: 7782600
-
Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.Epilepsy Res. 1990 Jul;6(2):134-40. doi: 10.1016/0920-1211(90)90088-d. Epilepsy Res. 1990. PMID: 2201541 Clinical Trial.
-
Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.J Child Neurol. 1990 Apr;5(2):159-65. doi: 10.1177/088307389000500219. J Child Neurol. 1990. PMID: 2111837 Clinical Trial.
-
Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.Seizure. 2010 Jul;19(6):356-8. doi: 10.1016/j.seizure.2010.05.002. Epub 2010 Jun 9. Seizure. 2010. PMID: 20538492
-
Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.J Ment Defic Res. 1991 Jun;35 ( Pt 3):231-9. doi: 10.1111/j.1365-2788.1991.tb01056.x. J Ment Defic Res. 1991. PMID: 1920391 Clinical Trial.
Cited by
-
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications.Clin Pharmacokinet. 1992 Jan;22(1):11-21. doi: 10.2165/00003088-199222010-00002. Clin Pharmacokinet. 1992. PMID: 1559305 Review.
-
Childhood Epilepsy : Current Therapeutic Recommendations.CNS Drugs. 1994 Mar;1(3):180-92. doi: 10.2165/00023210-199401030-00003. CNS Drugs. 1994. PMID: 27520517
-
Types of psychiatric treatment. Drug treatment.Arch Dis Child. 1992 Dec;67(12):1488-94. doi: 10.1136/adc.67.12.1488. Arch Dis Child. 1992. PMID: 1489231 Free PMC article. Review. No abstract available.
-
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.Br J Clin Pharmacol. 1993 Sep;36(3):257-61. doi: 10.1111/j.1365-2125.1993.tb04226.x. Br J Clin Pharmacol. 1993. PMID: 9114913 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004. Clin Pharmacokinet. 1995. PMID: 8582119 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical